Thermo Fisher Scientific Releases Gene Synthesis and Genome Editing Products in China

As the market for synthetic biology grows, customers can now access proven GeneArt products

CARLSBAD, California, Sept. 4, 2018 /PRNewswire/ — Asia Pacific is predicted to be the fastest growing market for synthetic biology from 2018 to 2025, driving increased demand for genome editing and gene synthesis technologies. To fulfill researchers’ needs, Thermo Fisher Scientific Inc., the world leader in serving science, is now offering its portfolio of Invitrogen GeneArt products and services in China.

“Scientists in China are increasingly using synthetic biology for basic research and more targeted translational R&D initiatives, such as screening for biomarkers in cancer research or developing new approaches to cancer therapies,” said Helge Bastian, vice president and general manager of synthetic biology at Thermo Fisher. “In addition, many start-up companies are leveraging our ability to design, write, edit, modify and manufacture the digital code of biology—namely nucleic acids—for game-changing applications that spread across a wide range of industries from clinical markets to various consumer end-users. In response to the growing customer demand for more efficient, reliable gene synthesis and genome editing technologies, we are launching our line of GeneArt products in China. GeneArt products will not only enable our customers to continually enhance our understanding of how biology works, it will also help them accelerate the path from planning experiments to executing them in the lab.”

With the Invitrogen GeneArt product line, researchers in China now have access to:

• Invitrogen GeneArt Gene Synthesis Service: Thermo Fisher’s team of highly skilled scientists design and synthesize genes in-house for superior protein production and sequence accuracy. The team has successfully produced more than 900,000 constructs for customers as diverse as large pharmaceutical companies, biotechnology startups and basic research institutions. Genes are assembled on an industrial scale for rapid order fulfillment and all constructs are sequence-verified; only those that match the requested sequence are shipped.
• GeneArt Strings DNA Fragments and Libraries: Assembled using the same high-quality process developed for GeneArt Gene Synthesis, GeneArt Strings DNA Fragments are uncloned, double-stranded, sequence-verified linear DNA fragments. Compared to similar solutions, GeneArt Strings DNA Fragments have better sequencing accuracy, reducing the screening effort to obtain a correct clone. GeneArt Strings DNA Fragments and Libraries offer full gene design and cloning flexibility and can be optimized for protein expression.
• GeneArt Genome Editing Tools: Thermo Fisher has developed the only complete toolset for every step in the cell engineering workflow. Designed to work together, the collection of optimized, validated technology systems includes solutions for both CRISPR- and TALEN-based genome editing. The toolkit offers products such as GeneArt CRISPR Nuclease mRNA, GeneArt Genomic Cleavage Detection Kits, GeneArt PerfectMatch TAL effectors and GeneArt Precision TAL effectors.

“Thermo Fisher’s GeneArt technology was integral in our research on insect resistance and molecular toxicology,” said Yi-Hua Yang, professor at the College of Plant Protection, Nanjing Agricultural University. “The technology not only enabled us to knock out and validate a receptor for Bt toxins used in insect controls, we were also able to demonstrate that the CRISPR-Cas9 technique can act as a powerful and efficient genome editing tool to study gene function in a global agricultural pest.”

GeneArt products are available for purchase within Thermo Fisher’s online order portal.

For more information on Thermo Fisher’s genome editing products and services, please visit: www.thermofisher.com/genomeediting

PRODUCTS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.

Thermo Fisher Scientific

Photo – https://mma.prnewswire.com/media/490330/Thermo_Fisher_Scientific.jpg

Share this: